NHLBI launches innovative proteomics centers

ry of potential new clinical applications from research into practice."

Topics to be investigated by the centers include:

    Protein profiling, which quantifies a large number of different proteins in order to reveal molecular pathways
    Post-translation modifications, which examine how modifying a protein's structure alters its function
    Protein interactions, which look at how proteins interact with themselves and various cellular factors

The 10 new NHLBI Proteomics Centers are:
    Three-D Proteomics and Aptemeric Arrays for Cystic Fibrosis at the Henry M. Jackson Foundation for the Advancement of Military Medicine, in Rockville, MD
    Cardiovascular Proteomics Center at the Medical University of South Carolina in Charleston
    Development of Novel Mass Spectrometry Tools for Individual Cell Proteome Analysis at the Medical College of Wisconsin in Milwaukee
    NHLBI Proteomics Center at Yale University in New Haven, CT
    NHLBI Proteomics Center at The Institute for Systems Biology in Seattle, WA
    Oxidative Protein Modifications in Cardiovascular Disease at Boston University in MA
    Proteomic Analysis of Blood Components in Autoimmune Disease at Stanford University in Stanford, CA
    Proteomic Technologies to Study Airway Inflammation at the University of Texas Medical Branch at Galveston
    Proteomics of Adaptation to Ischemia/Hypoxia in the Heart, Lung, and Blood at The Johns Hopkins University School of Medicine in Baltimore, MD
    Southwestern Center for Proteomics Research at the University of Texas Southwestern Medical Center in Dallas


Contact: NHLBI Communications Office
NIH/National Heart, Lung, and Blood Institute

Page: 1 2

Related biology news :

1. NHLBI awards $68 million to fund clinical centers in pediatric heart disease
2. NHLBI study finds improved heart failure survival
3. NHLBI study finds DASH diet and reduced sodium lowers blood pressure for all
4. NHLBI supported study finds inhaled steroids accelerate bone loss in women with asthma -- treatment still recommended for persistent asthma
5. NHLBI unveils new resources to help consumers control their blood pressure
6. NHLBI study shows reduced fat intake to lower cholesterol is safe and beneficial for children
7. Reducing sodium leads to substantial drop in blood pressure, finds NHLBI study
8. NHLBI launches genomic applications initiative -- $37 million awarded in initial effort
9. Two NHLBI studies confirm finding of gene in primary pulmonary hypertension
10. NHLBI study shows large blood pressure benefit from reduced dietary sodium
11. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research

Post Your Comments:

(Date:5/28/2020)... ... May 28, 2020 , ... ... for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains ... segments with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, ... TCR-based therapeutics, has implemented Genedata Biologics ® within their R&D organization. ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... and medical screening, announces the launch of a testing service aimed at ... The new service is provided by ClearStar’s Medical Information Services (“MIS”) business ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 06, 2020 , ... R3 ... new program featuring up to 200 million stem cells. Depending on the patient's condition, ... seniors in the US will die having some form of Alzheimers dementia, and the ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... develop a vaccine or drug treatment. In an effort to better understand the ... released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 ...
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
Breaking Biology Technology:
Cached News: